Skip to main content
/
Solventum Corporation (SOLV)
NYSE: SOLV · Real-Time Price · USD
76.04
+1.29 (1.73%)
At close: Mar 31, 2025, 4:00 PM
75.64
-0.40 (-0.53%)
After-hours: Mar 31, 2025, 8:00 PM EDT

Solventum Revenue

In the year 2024, Solventum had annual revenue of $8.25B with 0.70% growth. Solventum had revenue of $2.08B in the quarter ending December 31, 2024, with 1.92% growth.

Revenue (ttm)
$8.25B
Revenue Growth
+0.70%
P/S Ratio
1.60
Revenue / Employee
$375,182
Employees
22,000
Market Cap
13.16B

Revenue Chart

Created with Highcharts 11.4.8Solventum Revenue - Annual7.28B​7.28B8.17B​8.17B8.13B​8.13B8.20B​8.20B8.25B​8.25B20202021202220232024-2B4B6B8B

History

Fiscal Year End Revenue Change Growth
Dec 31, 20248.25B57.00M0.70%
Dec 31, 20238.20B67.00M0.82%
Dec 31, 20228.13B-41.00M-0.50%
Dec 31, 20218.17B890.00M12.22%
Dec 31, 20207.28B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

SOLV News

More News